US industrial gases producer Air Products has signed a long-term contract to build a new state-of-the-art plant to supply an unnamed manufacturer of memory chips on-site...

DCAT Value Chain Insights rounds up recent expansion activity for highly potent drug substances and drug products.

The pharmaceutical industry is increasingly focused on the development of specialized drug products with new treatment modalities, including previously undruggable...

Online Monitoring and Control of Bioreactors by Mid-Infrared Spectroscopy

Invista Performance Technologies (IPT) has won two separate contracts to supply its PTA technology for projects in China and Turkey.

Catalent Gene Therapy, a unit of US-based CDMO Catalent, is spending $130 million on five new Phase 3-through commercial-scale manufacturing suites at its gene therapy...

The production of biobased products using biotechnological processes offers great potential for resource efficiency.

As a production and innovation partner, JRS Contract Manufacturing supports those involved in special projects in product development, series start-ups, implementation of...

For biopharma leaders it is more critical than ever to secure the capabilities to contain, handle, develop and manufacture highly potent APIs.